COO
COOPER COMPANIES, INC.
NASDAQ · Healthcare · Medical - Instruments & Supplies · US
$58.16
+0.38%Year over year
Reported trailing growth
- Revenue
- +4.7%
- EBITDA
- -16.6%
- EBIT
- -26.5%
- EPS
- +43.7%
- Free cash flow
- +64.6%
- Operating cash flow
- +26.6%
Forward estimates
Based on analyst estimates
- Revenue
- +2.4%
- EBITDA
- +77.7%
- EPS
- +55.8%
Three-year CAGR
- Revenue
- +7.3%
- EBITDA
- +6.2%
- EBIT
- +10.4%
- Net income
- -1.0%
- EPS
- -1.4%
- Free cash flow
- -1.3%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jul 1, 2026